This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Praveen Anand: Innovator in T-Cell Therapy
Introduction
Praveen Anand is an accomplished inventor based in Allston, MA (US). He has made significant contributions to the field of medical research, particularly in the area of T-cell therapy for leukemia. His innovative approach aims to address critical challenges in treating T-cell acute lymphoblastic leukemia.
Latest Patents
Praveen Anand holds a patent titled "Targeting Galectin-9 as a Therapeutic Strategy for T-Cell Exhaustion in T-Cell Acute Lymphoblastic Leukemia." This patent represents a novel therapeutic strategy that could potentially improve treatment outcomes for patients suffering from this aggressive form of leukemia. He has 1 patent to his name.
Career Highlights
Anand is currently affiliated with Brigham and Women's Hospital, Inc., where he conducts research and develops innovative therapies. His work is characterized by a commitment to advancing medical science and improving patient care through targeted therapies.
Collaborations
Throughout his career, Praveen has collaborated with notable colleagues, including Amy Guillaumet-Adkins and Jens G. Lohr. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Praveen Anand is a pioneering inventor whose work in T-cell therapy holds promise for improving treatment options for leukemia patients. His contributions to medical research exemplify the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile